Xcout Intel
ChromaCode, Inc.
ChromaCode, Inc. is a for-profit company located in Carlsbad, California, offering HDPCR multiplexing technology solutions.
Subscribe to see ChromaCode, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ChromaCode, Inc. at a glance
ChromaCode, Inc. is a diagnostics company headquartered in United States. Its most recent funding round raised $3.8M in January 2025. Xcout tracks 4 named people at ChromaCode, Inc., including Paul Flook (Chief Executive Officer).
ChromaCode, Inc. leadership
- Paul FlookChief Executive Officer
- Paul FlookExecutive Officer
- Aditya RajagopalDirector
- Justin KleinDirector
ChromaCode, Inc. funding rounds
The 4 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $3.8M | — | |
| SEC Form D filing | $38M | — | |
| Series C | $10M | 1 named | |
| SEC Form D filing | $38.6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
ChromaCode, Inc. competitors
A few of ChromaCode, Inc.'s closest competitors — see the full list of competitors and alternatives →
QuantumCyte, Inc. operates in the biotechnology research industry, focusing on specialized cellular and tissue analysis solutions. Founded in 2013, the company is headquartered in Fremont, California.
Newomics Inc. is a privately-held biotechnology company headquartered in California that develops and commercializes advanced mass spectrometry solutions. The company provides innovative front-end systems and analytical tools for life sciences and research markets.
Stilla Technologies is a European biotechnology company based in Paris, France, that specializes in multiplex digital PCR. The company accelerates the development of next-generation genetic tests and maintains global distribution partnerships.
Countable Corp. (operating as Countable Labs) develops and manufactures instruments, assays, and platforms for high-precision PCR DNA and RNA detection. Serving researchers, clinical laboratories, and life sciences organizations, the company provides tools for rare event detection, cell and gene therapy, and molecular diagnostics.
Biotrove, Inc., founded in 1997, is a developer and manufacturer of genomic analysis instruments, consumables, and technology platforms such as OpenArray. The company provides systems and services for molecular diagnostics, high-throughput screening, drug discovery, and life sciences research.
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.
Get ChromaCode, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ChromaCode, Inc. in Xcout Intel
- 4 named people with titles, LinkedIn and board committees
- 7 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access